A number of reports suggest that HSP90 may be a viable target for neuroprotection, as HSP90 inhibitors have been found to promote HSF1 release and augment the heat-shock response, which protects against neurotoxic insults in a variety of models of neurodegenerative disease [58,59]. Here, HSF1 is linked to neurodegenerative disease.